Patents Assigned to Ampere Life Sciences, Inc.
  • TREATMENT OF MITOCHONDRIAL DISEASES WITH VITAMIN K
    Publication number: 20140031432
    Abstract: Methods of treating, preventing or suppressing symptoms associated with mitochondrial diseases, such as Friedreich's ataxia (FRDA), Leber's Hereditary Optic Neuropathy (LHON), dominant optic atrophy (DOA); mitochondrial myopathy, encephalopathy, lactacidosis, stroke (MELAS), Leigh syndrome or Kearns-Sayre Syndrome (KSS) with vitamin K are disclosed.
    Type: Application
    Filed: August 4, 2011
    Publication date: January 30, 2014
    Applicant: Ampere Life Sciences, Inc.
    Inventors: Orion D. Jankowski, Andrew W. Hinman, Guy M. Miller
  • CHROMAN DERIVATIVES
    Publication number: 20120088783
    Abstract: The invention relates to novel chroman derivatives, stereoisomers and pharmaceutically acceptable salts of Formula I wherein the substituents are as defined in the specification. They are useful in the treatment of disorders mediated by lipoxygenase, such as immune diseases, respiratory diseases and cardiovascular diseases, as well as in the treatment of neurodegenerative disorders and/or mitochondria) disorders. They are also useful in the manufacture of pharmaceutical formulations for the treatment of such conditions.
    Type: Application
    Filed: September 26, 2011
    Publication date: April 12, 2012
    Applicant: Ampere Life Sciences, Inc.
    Inventors: Bing WANG, Gail Walkinshaw, Donald R. James
  • Chroman derivatives
    Patent number: 8044097
    Abstract: The invention relates to novel chroman derivatives, stereoisomers and pharmaceutically acceptable salts of Formula I wherein the substituents are as defined in the specification. They are useful in the treatment of disorders mediated by lipoxygenase, such as immune diseases, respiratory diseases and cardiovascular diseases, as well as in the treatment of neurodegenerative disorders and/or mitochondria) disorders. They are also useful in the manufacture of pharmaceutical formulations for the treatment of such conditions.
    Type: Grant
    Filed: February 26, 2009
    Date of Patent: October 25, 2011
    Assignee: Ampere Life Sciences, Inc.
    Inventors: Bing Wang, Jian Chen
  • 7,8-bicycloakyl-chroman derivatives
    Patent number: 7875607
    Abstract: 7,8-Bicyclic-chroman derivatives of Formula I: wherein the substituents are defined as in the specification or the pharmaceutically acceptable salts thereof, are disclosed. They are useful for the treatment of inflammatory disorders, neurodegenerative disorders and/or mitochondrial disorders. They are also useful in the manufacture of pharmaceutical formulations for the treatment of such conditions.
    Type: Grant
    Filed: November 24, 2008
    Date of Patent: January 25, 2011
    Assignee: Ampere Life Sciences, Inc.
    Inventors: Bing Wang, Gail Walkinshaw